The resulting p53 dysfunction in CAFs alters the molecular crosstalk between the tumour stroma and cancer cells through the enhanced production of CXCL12, IL-6, and SDF-1 to promote inflammation and oncogenic signals (Figure 2B) [3,88,89,90]. The gene discussed is TP53; the disease is neoplasm.